Mucosa-associated lymphoid tissue lymphoma of the trachea treated with radiotherapy: A case report

Table 1 The literature review of bronchus-associated lymphoid tissue lymphoma

Number	Treatment	Dose of radiation	Response	Outcome	Ref.
61	Surgery (21), Surgery + chemotherapy (16), Surgery + radiation (3), Surgery + chemotherapy + radiation (2), Chemotherapy (16), Observation (3)	Not reported	Not reported	5-year OS 93.6%	Cordier et al[5]
19	Chemotherapy (14), Surgery (2), Surgery + chemotherapy (2), Chemotherapy + radiation (1)	Not reported	79% CR, 21% PR	Not reported	Zinzani et al[17]
41	Observation (5), Surgery (17), Chemotherapy (12), Surgery + chemotherapy (3), Surgery + radiation (1), Prednisone (2), Unknown (1)	Not reported	Not reported	Lymphoma-specificsurvival was 71.7% at 10 years	Kurtin et al[18]
22	Observation (2), Chemotherapy alone (2), Rituximab alone (2), Systemic chemotherapy ± Rituximab (12), Chemotherapy with rituximab (8), Surgery (6), Radiotherapy (2)	Not reported	--, 2 PR, 2 PR, 2 CR, 9 PR, 1 SD, 2 CR, 5 PR, 1 SD, 6 CR, 1 CR, 1 PR	53 mo median PFS	Ahmed et al[19]
18	Observation (1), Surgery (6), Surgery + chemotherapy (8), Surgery + radiotherapy (1), Surgery + chemotherapy + radiotherapy (2)	Not reported	Not reported	6 years median time to disease recurrence or death	Graham et al[20]
61	Surgery alone (17), Surgery + Chemotherapy (3), Surgery + Radiotherapy (2), Chemotherapy (28), Radiotherapy (6), Observation (5)	Not reported	15 CR, 2 PR, 3 CR, 2 CR, 7 CR, 12 PR, 5 SD, 2 PD, 2 not valuable, 3 CR, 2 PR, 1 SD, 5 not valuable	median time to progression was 5.6 years. 5-year OS 89.7%	Oh et al[21]
10	Radiotherapy ± surgery ± chemotherapy ± rituximab	2 Gy × 2	6 CR, 4 PR	87.5% 5-year progression-free survival rate	Girinsky et al[15]
1	Radiotherapy (1)	30 Gy	CR	No signs of recurrence are found 4 years after radiotherapy	Hashemi et al[13]
2	Radiotherapy + rituximab (1), Observation (1)	50 Gy	CR, --	Not reported	Kawaguchi et al[14]
1	Radiotherapy (1)	30.6 Gy	CR	Survive more than 3.5 years	Our case

OS: Overall Survival; PFS: Progression-Free Survival; CR: Complete Response; PR: Partial Response; SD: Stable Disease; PD: Progressive Disease.